Compare LTC Properties Inc (LTC) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LTC Properties Inc vs Twist Bioscience Corp — how do they compare? LTC Properties Inc trades at $42.46 (market cap $2.27B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: Twist Bioscience Corp is far larger — about 4.4× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.42% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold LTC Properties Inc for 88 Days and Twist Bioscience Corp for 27 Days on average.
| LTC | TWST | |
|---|---|---|
Market Cap | $2.27B | $10.08B |
Volume | 574,171 | 4,229,037 |
Sector | Real Estate | Health |
52-Week High | $43.50 | $205.00 |
52-Week Low | $33.98 | $25.45 |
Typical Hold Time | 88 Days | 27 Days |
Enterprise Value | $3.01B | $10.01B |
Dividend Yield | 5.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LTC Properties trades at $42.05, up 0.57% today, with a mixed technical picture showing bearish overall signals but bullish moving averages. The REIT demonstrates strong fundamentals with 38.93% net income margin and consistent dividend payments. Recent acquisitions totaling $160 million in senior housing properties signal aggressive growth strategy, while analyst consensus targets $49.67 with 32% buy ratings.
LTC presents a balanced opportunity with steady income from monthly dividends and strategic SHOP portfolio expansion, though elevated debt levels and rising interest rates pose headwinds. The stock trades below analyst targets but faces execution risks in its transition to 75% SHOP NOI by 2028.
Twist Bioscience (TWST) trades at $152.05, down 2.31% today but remains near recent highs following a significant rally driven by AI partnerships and strong sector interest. The company shows improving revenue growth ($377M in 2025) but continues to post substantial losses (-$78M net income). Technical indicators show mixed signals with bullish overall sentiment but bearish moving averages, while analyst consensus remains positive with 73% buy ratings.
TWST presents a high-risk, high-reward opportunity with strong growth potential through AI-driven drug discovery partnerships but faces significant execution risks amid persistent profitability challenges. The stock's valuation appears stretched given current fundamentals, requiring successful commercialization of pipeline assets to justify premium multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
